Pulmonary Embolism Deaths Rising Among Younger Americans

Approximately 90,000 to 270,000 Americans die from pulmonary embolism annually, with one-third of survivors experiencing recurrence within 10 years.
The heart continues to strain, eventually enlarging and potentially failing
What happens inside the body when a blood clot blocks blood flow to the lungs.
Mark

So 900,000 Americans a year develop this, and we're seeing more deaths in younger people. What changed?

Mimi

The death rate had actually been falling from 1999 to 2008. But since then it's been rising again, about 0.06 percent per year, and it's concentrated in people under 65. We don't know exactly why from this reporting, but the shift is real.

Luke

Wait—0.06 percent per year sounds small. How many actual deaths are we talking about?

Mimi

If 10 to 30 percent of the 900,000 diagnosed die within a month, that's somewhere between 90,000 and 270,000 deaths annually. The 0.06 percent is the rate of increase, not the total.

Mark

And a third of survivors get another one within ten years?

Mimi

Yes. So it's not just about surviving the first episode. It's a chronic risk.

Luke

The article mentions risk factors—surgery, pregnancy, long flights, obesity, smoking. Are those new risks, or are younger people just doing these things more?

Mimi

The article doesn't say. It lists the risk factors but doesn't explain why younger people are suddenly dying at higher rates. That's the real question.

Mark

What about diagnosis? Is it getting missed in younger people?

Mimi

The symptoms are tricky—shortness of breath, chest pain, heart palpitations. A 40-year-old might think it's anxiety. By the time imaging confirms it, the clot has done damage.

Luke

So the story is partly about detection lag in a population that might not expect to have a life-threatening clot?

Mimi

That's part of it. The other part is that once you have one, your risk goes up significantly. Prevention and early treatment become critical.

Mark

And prevention is pretty straightforward—move around, stay hydrated, compression stockings if you're at risk?

Mimi

Yes. But you have to know you're at risk first. That's the gap.

  • After years of progress, PE death rates have been quietly climbing since 2010 — and the rise is sharpest among people under 65, a population least likely to suspect their own vulnerability.
  • The clot often begins unannounced in the legs, then breaks free and travels to the lungs, where it forces the heart into a losing battle against rising pressure and diminishing oxygen.
  • Symptoms mimic anxiety, muscle strain, or indigestion — chest pain, breathlessness, dizziness — making self-recognition difficult and delayed diagnosis dangerously common.
  • Doctors are working against a narrow window: anticoagulants, catheter-delivered clot dissolvers, and compression stockings can reverse the damage, but only if the condition is caught early enough.
  • Prevention remains the most democratic tool available — regular movement, hydration, and awareness of risk factors like surgery, prolonged immobility, obesity, and hormonal medications.
  • One in three survivors will face a recurrence within a decade, making this not a single crisis but an ongoing negotiation between the body and its own clotting tendencies.

Each year, nearly 900,000 Americans find themselves in the path of a silent and often misread threat — a blood clot that migrates from the legs to the lungs, cutting off oxygen and straining the heart toward failure. Pulmonary embolism, once declining in its mortality, has reversed course since 2008, now claiming between 90,000 and 270,000 lives annually, with younger Americans increasingly among the fallen. The condition asks something of us collectively: that we learn to recognize what the body is trying to say before the window for intervention closes.

Nearly 900,000 Americans develop a pulmonary embolism each year, and the numbers carry a quiet gravity: between 10 and 30 percent of those diagnosed die within a month, and a third of survivors will face another clot within the next decade. What makes the moment particularly urgent is a demographic shift — after PE death rates declined steadily through the early 2000s, they have been rising again since 2010, and the increase is concentrated among people under 65.

The condition typically begins as a deep vein thrombosis in the legs or pelvis. When that clot breaks free and lodges in the lungs, it cuts off oxygen to surrounding tissue and forces the heart to work harder against rising pulmonary pressure. Left untreated, the heart strains, enlarges, and can fail. In some cases, multiple clots accumulate and destroy entire sections of lung function.

Risk factors span the inherited and the circumstantial — genetic clotting disorders, prior heart attack or stroke, cancer, pregnancy, hormonal birth control, obesity, smoking, and the simple act of sitting motionless for hours during travel or recovery. The triggers are common enough that almost anyone might qualify.

Diagnosis is complicated by symptoms that resemble other conditions: shortness of breath, chest pain, palpitations, dizziness, or fainting. Imaging — CT scans, ultrasound, angiography — is required to confirm what the body is signaling. Treatment centers on anticoagulation to stop clot growth, and in severe cases, catheter-delivered drugs to dissolve the blockage directly.

Dr. Omar Haqqani, Chief of Vascular and Endovascular Surgery at Vascular Health Clinics in Midland, stresses that the difference between early and late diagnosis can be the difference between recovery and death. Prevention — moving every one to two hours, staying hydrated, wearing compression stockings when immobility is unavoidable — remains the most accessible line of defense for those who don't yet know they are at risk.

Nearly 900,000 Americans develop a pulmonary embolism each year, a condition in which a blood clot travels through the veins and lodges in the lungs, blocking blood flow to vital tissue. The numbers are sobering: between 10 and 30 percent of those diagnosed die within a month. A third of the survivors will face another clot within the next decade. What makes this particularly urgent now is a shift in who is being affected. After death rates from PE declined steadily between 1999 and 2008, they have begun climbing again—rising roughly 0.06 percent annually since 2010—and the increase is concentrated among people under 65.

Understanding what happens inside the body helps explain why early detection matters so much. A pulmonary embolism typically begins as a deep vein thrombosis, a clot that forms in the legs or pelvis. When that clot breaks free and travels to the lungs, it wedges itself into a blood vessel and cuts off oxygen supply to the surrounding lung tissue. The heart, sensing the obstruction, works harder to push blood through. Blood pressure in the lungs rises. If the clot is not removed or dissolved, the heart continues to strain, eventually enlarging and potentially failing altogether. In some cases, multiple clots accumulate, a condition called pulmonary infarction, which can destroy entire sections of lung function.

The risk factors are numerous and often interconnected. Some are inherited—a family history of blood clots or a genetic clotting disorder puts a person at higher baseline risk. Others stem from medical events: surgery, trauma, fractures of the hip or leg, a previous heart attack or stroke. Pregnancy and hormonal birth control both increase clotting risk. Cancer and its treatments do as well. But many of the most common triggers are behavioral or circumstantial. Sitting or standing motionless for extended periods—during long car rides, airplane flights, or bed rest after surgery—allows blood to pool in the legs. Obesity and smoking both contribute. Even the simple act of maintaining a cramped position for hours can initiate clot formation.

Recognizing the symptoms is complicated because they overlap with many other conditions. A deep vein thrombosis may announce itself with pain, redness, swelling, or warmth at the site of the clot, usually in the leg. But a pulmonary embolism itself can feel like something else entirely: shortness of breath, chest pain that radiates to the jaw or shoulder, heart palpitations, rapid breathing, dizziness, or fainting. Some people experience low blood pressure, cough up blood, or sweat profusely. Anxiety and restlessness can occur. The symptom list is long enough that diagnosis requires imaging. Doctors use chest X-rays, electrocardiograms, blood tests, CT scans, ultrasound, and in some cases angiography—a procedure in which dye is injected into the veins to make them visible on X-ray.

Once diagnosed, treatment focuses on two goals: dissolving the existing clot and preventing new ones from forming. Anticoagulation medications thin the blood and stop clots from growing. Compression stockings reduce swelling and prevent blood from pooling in the veins. In more severe cases, doctors may use catheters to deliver clot-dissolving drugs directly to the site of the blockage. Prevention, though, remains the most accessible intervention. Moving regularly—standing or walking every one to two hours—keeps blood circulating. Staying hydrated helps. Avoiding medications that promote clotting is important for those at risk. For people facing surgery or prolonged immobility, a doctor may recommend compression stockings as a preventive measure.

The rising death rate among younger Americans suggests that awareness and early intervention are not reaching everyone who needs them. A person in their forties or fifties might not recognize the warning signs, or might attribute chest pain and shortness of breath to anxiety or a pulled muscle. By the time a diagnosis is made, the clot may have caused significant damage. The window for effective treatment is narrow. This is why Dr. Omar Haqqani, Chief of Vascular and Endovascular Surgery at Vascular Health Clinics in Midland, emphasizes that early diagnosis and treatment are not merely helpful—they are essential. The difference between catching a pulmonary embolism in its first hours and discovering it days later can be the difference between recovery and death.

Early diagnosis and treatment are extremely important
— Dr. Omar Haqqani, Chief of Vascular and Endovascular Surgery at Vascular Health Clinics
Quer a matéria completa? Leia o original em The Pioneer ↗
Fale Conosco FAQ